Search for: "Eli Lilly "
Results 1381 - 1400
of 2,131
Sort by Relevance
|
Sort by Date
9 Sep 2010, 7:09 pm
See Eli Lilly, 471 F.3d at 1377-79. [read post]
8 Sep 2010, 7:35 am
The Vodafone judgment is available here. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen, ‘yes’ to… [read post]
7 Sep 2010, 12:25 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
6 Sep 2010, 9:48 pm
Noonan -- The old proverb "success has many fathers, while failure is an orphan" comes to mind when considering the Federal Circuit's decision in Eli Lilly & Co. v. [read post]
4 Sep 2010, 8:29 pm
Eli Lilly v. [read post]
2 Sep 2010, 7:01 am
Discussions went beyond swelling and weight gain to comparisons with other products shown to lower blood sugar without these risks, such as Eli Lilly/Amylin's Byetta and Merck's Januvia. [read post]
1 Sep 2010, 9:59 pm
Court of Appeals for the Federal Circuit issued an Order today in Eli Lilly & Co. v. [read post]
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Mirapex (Pramipexole) – US: Mirapex case ends, Mylan Found to infringe Boehringer patent (Patent Docs) Moviprep (Polyethylene glycol) – US: Salix settles with Novel over Moviprep (IPBiz) Norvir (Ritonavir) – US: PUBPAT challenges eight of Abbott’s HIV/AIDS medicine patents (IP Watch) Strattera (Atomoxetine) – US: Eli Lilly granted 14-day injunction prohibiting production of generic Strattera:… [read post]
30 Aug 2010, 9:55 pm
Court of Appeals for the Federal Circuit issued an Order in Eli Lilly & Co. v. [read post]
30 Aug 2010, 8:18 am
Past participants have included representatives from Procter & Gamble, Caterpillar, SC Johnson, Pfizer, Eli Lilly and others.Limited to senior-level corporate counsel, the CPS is an informal group of patent professionals who exist only for the purpose of putting this seminar together. [read post]
29 Aug 2010, 8:41 pm
Eli Lilly and Company v. [read post]
29 Aug 2010, 7:27 pm
Eli Lilly has it. [read post]
29 Aug 2010, 11:23 am
Last week Eli Lilly, one of the largest pharmaceutical companies in the world, announced that it was halting two trials on what was previously a promising Alzheimer’s drug. [read post]
27 Aug 2010, 9:54 pm
Eli Lilly; • Drafting of Second Medical Use Claims after G2/08: How to ensure that a patent is likely to be valid; • The current state of play for biosimilars in the U.S. and in Europe: Where do... [read post]
27 Aug 2010, 7:07 am
Recently, drug maker Eli Lilly asked the FDA to allow it to sell its antidepressant Cymbalta (duloxetine) as a treatment for chronic pain. [read post]
25 Aug 2010, 6:58 am
Recently, A federal advisory panel to the Food and Drug Administration “voted narrowly to recommend allowing Eli Lilly to market its blockbuster antidepressant, Cymbalta, for some chronic pain conditions affecting millions of Americans, particularly lower back pain. [read post]
24 Aug 2010, 8:11 am
Eli Lilly & Co., supra, 44 Cal.3d 1103, 1110, 245 Cal.Rptr. 658, 751 P.2d 923 (1988). [read post]
22 Aug 2010, 10:16 pm
Pfizer, GlaxoSmithKline, Merck, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Baxter, SciClone are a few of the drug manufacturers that the United States Department of Justice (DOJ) is investigating for violation of bribery laws and corruption in foreign markets under the Foreign Corrupt Practices Act. [read post]
20 Aug 2010, 12:56 pm
Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry * BMS and Allergan * Merck and Schering-Plough * Sanofi-Aventis and Intelliject * J&J and Takeda * Eli Lilly and Kowa Pharmaceuticals * Eli Lilly and Incyte Corporation The Perfect Pitch: Biotech Investment Challenge In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early… [read post]
